Efficacy and Safety Evaluation of IM19 CAR-T Cell Therapy for MRD+ After Transplantation
Clinical trial NCT04336501 · UNKNOWN
Trial details
- NCT number
- NCT04336501
- Sponsor
- Beijing Immunochina Medical Science & Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-01
- Primary completion
- 2021-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.